Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Not all low-cost index funds support drip, so compare available options and setup steps to automate reinvestment and maximize growth.
26,805 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Palo Alto Networks has seen a meaningful pullback, but a dip can become a doorway for patient investors. This guide b...
Oracle defies the mood of a bruised AI rally, with Jefferies sticking to a buy and highlighting accelerating cloud gr...
Wells Fargo lifts its NVIDIA price target to $315 ahead of the May earnings release, maintaining an Overweight rating...
A high-profile podium moment in Monaco shows how fame can translate into branding power and financial opportunity. Th...
Public sector workers can tap a 457(b) retirement account without the 10% penalty after leaving a job. Private-sector...
Bank of America named two new leaders to oversee digital assets and AI transformation, signaling a strategic push to ...
Crypto ETPs face a five-week pullback totaling about $4 billion as volumes sink to 2025 lows. Market watchers warn th...
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
Shaquille O’Neal credits a small, selfless moment from his father with shaping his approach to money, business, and g...
Apple is steering its AI push toward a hardware-driven revenue surge, potentially triggering a historic upgrade cycle...
In a market rattled by softer data, Coca-Cola’s traditional strengths keep drawing new and seasoned investors alike. ...